Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression Study: Continued Versus Washout
-
Published:2021-10
Issue:
Volume:
Page:
-
ISSN:0161-6420
-
Container-title:Ophthalmology
-
language:en
-
Short-container-title:Ophthalmology
Author:
Yam Jason C.ORCID,
Zhang Xiu Juan,
Zhang YuzhouORCID,
Wang Yu Meng,
Tang Shu Min,
Li Fen Fen,
Kam Ka WaiORCID,
Ko Simon T.,
Yip Benjamin H.K.ORCID,
Young Alvin L.,
Tham Clement C.ORCID,
Chen Li Jia,
Pang Chi Pui
Reference43 articles.
1. Myopia;Morgan;Lancet,2012
2. High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study;Yam;Acta Ophthalmol,2020
3. Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study;Zhang;Br J Ophthalmol,2021
4. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2);Chia;Ophthalmology,2012
5. Low-Concentration Atropine for Myopia Progression (LAMP) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control;Yam;Ophthalmology,2019
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献